Havila Shipping ASA: Kontraktsforlengelse for PSVene Havila Borg og Havila Herøy med Peterson den Helder BV
Peterson den Helder BV har erklært 12 måneders opsjon for PSVene Havila Borg og Havila Herøy.
Forlengelsen gjelder fram til April 2024
Kontakt:
Administrerende direktør Njål Sævik, +47 909 35 722
Finansdirektør Arne Johan Dale +47 909 87 706
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
Hvis du vil se dette innholdet fra www.globenewswire.com, gi ditt samtykke øverst på denne siden.Hvis du vil se dette innholdet fra ml-eu.globenewswire.com, gi ditt samtykke øverst på denne siden.
Om GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg pressemeldinger fra GlobeNewswire by notified
Registrer deg med din e-postadresse under for å få de nyeste sakene fra GlobeNewswire by notified på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra GlobeNewswire by notified
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership24.4.2024 15:00:00 CEST | Press release
LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensitive 4th generation multi-omics molecular biology, proudly announce a significant milestone in their collaboration. RenovaroCube has entered into an amendment to its binding letter of intent to acquire 100% ownership of Cyclomics, further cementing their shared commitment to advancing state-of-the-art technologies in cancer diagnostics and treatment. Their combined relationships with Oxford Nanopore and Nvidia will further position RenovaroCube to be a leader in early cancer diagnostics and monitoring of treatment efficacy. Oxford Nanopore is a leader in sequencing technologies and Nvidia will provide vital super computing power and front edge software solutions such as Parabricks, BioNeMo, Monai and Nemo. Initially set at a 75% acquisition, this decision to acquire the remaining 25% of Cy
FloQast Appoints Josh Glover as President and Chief Revenue Officer24.4.2024 15:00:00 CEST | Press release
Glover brings seasoned leadership to drive company momentum, oversee revenue growth, and market expansion LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- FloQast, a Finance and Accounting Operations Platform provider, today announced the appointment of Josh Glover as President and Chief Revenue Officer (CRO). Glover brings to FloQast an extensive background in leadership in both civilian and military roles and will be instrumental in driving FloQast’s current momentum both in terms of revenue growth, market expansion, and the development of new solutions to better the lives of accounting and finance professionals. Glover will oversee all go-to-market teams (sales, marketing, business development, and customer success) and will report to FloQast co-founder and CEO Mike Whitmire. As part of the transition, former CRO Ken Sims will assume the title of Chief Business Development Officer, a newly created role dedicated to driving growth for FloQast in both new and existing markets. Prior to
Blue Mountain Appoints Global Head of Marketing to Bolster Growth and Secure its Position as the EAM Industry Standard in the Life Sciences Sector24.4.2024 15:00:00 CEST | Press release
Veteran marketing leader to drive global awareness and adoption of their out-of-the-box fully validated EAM platform STATE COLLEGE, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Blue Mountain, the leader in GMP-compliant EAM (Enterprise Asset Management) software for life sciences, is pleased to announce the appointment of Jessica Brown as Global Head of Marketing and its newest addition to the executive team. With 20 years of experience in B2B SaaS marketing and a proven track record of driving growth in highly competitive markets, Jessica brings a wealth of expertise to Blue Mountain. In her previous roles, she has successfully developed and executed strategic marketing initiatives that have propelled companies to new heights of success. "On behalf of my entire team, we are overjoyed to welcome Jessica to Blue Mountain," said CEO, David Rode. "Her extensive experience and proven leadership in marketing to highly regulated industries will be instrumental in driving our growth initiatives. T
Harvia will publish its Interim Report for January−March 2024 on Friday, 3 May 2024 at around 9:00 a.m. EEST24.4.2024 15:00:00 CEST | Press release
Harvia Plc press release 24 April 2024 at 4:00 p.m. EEST Harvia will publish its Interim Report for the period of January−March 2024 on Friday, 3 May 2024 at around 09:00 a.m. Finnish time. The stock exchange release and the presentation material will be available after publishing at https://harviagroup.com/investor-relations/. Harvia will hold a webcast for analysts, investors and media on 3 May 2024 at 11:00 a.m. EEST. The conference will be held in English. Harvia’s CEO Matias Järnefelt and CFO Ari Vesterinen will host the event. The webcast can be followed at https://harvia.videosync.fi/q1-2024. A recording of the webcast will be available later at the company’s website at https://harviagroup.com/investor-relations/. HARVIA PLC For further information, please contact: CFO Ari Vesterinen, ari.vesterinen@harvia.com, tel. +358 40 5050 440 Harvia is one of the leading companies operating in the sauna and spa market globally, as measured by revenue. Harvia’s brands and product portfolio
Vedtægter for Novo Nordisk, april 202424.4.2024 14:56:59 CEST | pressemeddelelse
Vedtægter for Novo Nordisk, april 2024 Vedhæftet fil Vedtægter 24 Apr 2024